Sign Out
Symptoms and signs: Little information exists regarding DAYVIGO overdose. A dose-dependent increase in the incidence of somnolence was reported in an overseas clinical study of DAYVIGO administered up to 75 mg to healthy adult subjects.
Hypotonia, photopsia, hypoxia, initial insomnia, coldness, etc. were reported in clinical studies of DAYVIGO administered at >10 mg.
Treatment: No specific antidote exists for the treatment of DAYVIGO overdose. Common symptomatic therapy should be provided in the event of overdose.
